AXIS Insurance, a business segment of AXIS Capital Holdings Limited (NYSE:AXS), today announced the appointment of Max Perkins in the newly created role of Head of Strategy and Innovation for the Company’s Global Cyber and Technology unit, effective immediately. Mr. Perkins is based in the United States and reports to Dan Trueman, Global Head of Cyber and Technology for AXIS Insurance.

AXIS Insurance, a division of AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS), today announced the appointment of Daniel Stevens as Risk Engineer in its Renewable Energy team. In this newly created role, Mr. Stevens will work closely with AXIS Insurance’s Renewable Energy underwriters, as well as external parties involved in the development and management of renewable energy projects. This will enhance AXIS’ role as a risk partner to clients and a provider of renewable energy risk management expertise. Mr. Stevens is based in London and reports to Richard Carroll, Global Head of Renewable Energy at AXIS Insurance.

Clinical trial results suggest that an experimental treatment combining two already-approved drugs could make life easier for Alzheimer's patients and their caregivers.

Two positive late-stage clinical trials may just be the beginning.

AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS) today announced the appointment of Mark McCormick as CEO of AXIS Re SE ("ARe"), subject to regulatory approval. ARe is AXIS Capital’s reinsurance legal entity domiciled in Ireland and regulated by the Central Bank of Ireland ("CBI"), with a Zurich branch. In this role, Mr. McCormick will be responsible for ARe and the legal entity aspects of its Zurich branch. Mr. McCormick will also join the Board of Directors of AXIS Specialty Europe SE ("ASE") as a Non-Executive Director. ASE is AXIS Capital’s specialty insurance legal entity domiciled in Ireland and regulated by the CBI, with branches in London, Brussels and Amsterdam.

The biotech reported positive news from a late-stage clinical study targeting Alzheimer's disease agitation.

One biotech has been big long-time winner, the other is a promising up-and-comer with no revenue -- yet. But picking an investment is always a bet on the future.

The rock legend revealed the news to Dan Rather on the latter's AXS TV show The Big Interview. Jethro Tull Frontman Ian Anderson “Suffering from an Incurable Lung Disease” Spencer Kaufman

Axsome's Alzheimer's agitation drug AXS-05 met its primary endpoint.TRACON reports positive data from its cancer trial.Syndax has an update on its leukemia drug candidate.

AXS earnings call for the period ending March 31, 2020.

AXIS Capital Holdings Limited (NYSE:AXS) stock is about to trade ex-dividend in 3 days time. You can purchase shares...

Positive results from two pivotal trials helped this stock bounce back from a beatdown in March.

Key details in an antidepressant's clinical trial may signal a revolutionary therapy for patients.

Competition is about to ramp up significantly in the $1.7 billion market for treating chronic sleep disorder.

Just what exactly is going on with this company, which has had success in nearly every single clinical trial it initiated in recent years?

Sony announces release date for FX9 firmware update 2.0. Sony didn't try to keep the roadmap of the PXW-FX9 a secret. Virtually since it's inception in 2019, the company has shared its plans for the camera which would include 16-bit RAW external recording, …

Janelle Monáe will be the latest artist to perform in Verizon’s Pay It Forward Live entertainment series on Thursday, April 30 at 8 p.m. ET. | 5 p.m. PT. Donations made during the concert will benefit the Local Initiatives Support Corporation’s (LISC) Veriz…

After putting 40 bikes through their paces, our team had many things to say about the direction cycling is headed.

After suggesting that he wasn't going to live much longer, the legendary rocker has explained his comments. Jethro Tull’s Ian Anderson Clarifies Health Status: “My Days as a Singer Are Numbered, Rather Than Days to Live” Spencer Kaufman

The pharmaceutical company appears poised to earn multiple regulatory approvals in 2021. But has too much anticipated success already been priced into its shares?

AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS) today announced that its Board of Directors has declared a quarterly dividend of $0.41 per common share payable on July 15, 2020, to shareholders of record at the close of business on June 29, 2020.

Could AXIS Capital Holdings Limited (NYSE:AXS) be an attractive dividend share to own for the long haul? Investors are...

AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced that due to the public health impact of the novel coronavirus outbreak (COVID-19) and to support the health and well-being of its stakeholders, it will make available virtual access to its 2020 Annual General Meeting of Shareholders on May 7, 2020 at 8:30 AM ADT.

AXIS Capital Holdings Limited ("AXIS Capital" or "the Company") (NYSE:AXS) today announced financial results for the first quarter ended March 31, 2020.

Ian Anderson, frontman and flute player for Jethro Tull, has revealed that he's battling chronic obstructive pulmonary disease (COPD). "I'm going to tell you something I've never told anybody in public before," Anderson told Dan Rather during a recent intervi…

Public health and social measures necessitated by COVID-19 pandemic have proven difficult to implement, especially when they are strict and prolonged. So far, island states have received little attention in studies analysing the viability and effectiveness of…

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]

AXS earnings call for the period ending March 31, 2020.

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...

Chance the Rapper is teamimg up with Verizon for its weekly streaming entertainment series Pay It Forward Live in support of small businesses affected by COVID-19.

AXIS Insurance, a division of AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS), announced today that Michael Carr has been named the Head of U.S. Excess & Surplus Property. In this role, Mr. Carr will be responsible for developing and executing AXIS Insurance’s E&S Property underwriting strategy and achieving profitable growth along with quality and diversification of its underwriting portfolio. Mr. Carr reports into Carlton Maner, CEO of AXIS Insurance’s U.S. Division, and is based in the Company’s Alpharetta, Georgia, office.

AXSM earnings call for the period ending March 31, 2020.

Q1 2020 AXIS Capital Holdings Ltd Earnings Call

AXIS Capital's (AXS) first-quarter 2020 results reflect lower revenues and higher expenses incurred.

AXIS Capital Holdings Limited ("AXIS") (NYSE:AXS) today announced $1 million in targeted philanthropic donations to support COVID-19 relief and community support efforts. AXIS will partner with non-profit organizations providing pandemic relief globally, as well as in communities in which AXIS operates.

AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced that it expects to release financial results for the first quarter ended March 31, 2020, on Monday, May 4, 2020, after the close of the financial markets.

Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Guru's largest buys of 4th quarter Continue reading...

AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced an estimated net claims provision of $300 million, pre-tax, for the first quarter related to catastrophe and other weather-related events. This amount includes an estimated net claims provision of $235 million, pre-tax, for the COVID-19 pandemic.

AXIS Re, the reinsurance business segment of AXIS Capital Holdings Limited ("AXIS Capital") (NYSE: AXS), today announced the hiring of Mark Julian to the newly created position of Chief Pricing Actuary, effective April 20, 2020. In this role, Mr. Julian will oversee AXIS Re’s actuarial pricing and catastrophe modeling teams, which have been combined into a new Reinsurance Pricing operational division. Mr. Julian will be based in the Company’s London office and will be a member of the Reinsurance Leadership Team. He will report to AXIS Re CEO Steve Arora.